4Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature,1994, 369(6475): 64.
5Dahlback B, Carlsson M, Svensson. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. PNAS, 1993,90(3): 1004.
6Herrmann FH, Koesling M, Schroder W, et al. Prevalence of factor V Leiden mutation in various populations. Genet Epidemiol, 1997, 14(4):403.
7Nabavi DG, Junker R, Wolff E, et al. Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 255patients. J Neurol, 1998, 245(10): 653.
8De Lucia D, Papa ML, Ammendola F, et al. Association of elevated levels of prothrombin fragment 1 + 2 and Arg506 to Gln mutation in patients with a history of ischemic stroke. J Neurosurg Sci, 1999, 43(1): 45.
9Landi G, Cella E, Martinelli l, et al. Arg506 Gln factor V mutation and cerebral ischemia in the young. Stroke, 1996, 27(12): 1697.
10Thorvaldsen P, Asplund K, Kunlasmaa K, et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. Stroke, 1995, 26(3): 361.
6DAHL T,KONTNY F,SLAGSVOLD C E,et al.Lipoprotein(a),other lipoproteins and hemostatic profile with ischemic stroke:the relation to cardiogenic embolism[J].Cerebrovasc Dis,2000,10(2):110-117.
7ROSENDORFF A,DORFMAN D M.Activated protein C resistance and factor V Leiden:A review[J].Arch Pathol Lab Med,2007,131(6):866-871.
8van VLIET H,TCHAIKOVSKI S N,ROSENDAAL F R,et al.The effect of levonor-gestrel-releasing intrauterine system on the resistance to activated protain C(APC)[J].Thromb Haemost,2009,101(4):691-695.
